These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Atrial natriuretic factor in patients on continuous ambulatory peritoneal dialysis. Mora-Maciá J; Doñate T; Ocón J; Rodá M; del Río G Perit Dial Int; 1993; 13 Suppl 2():S190-1. PubMed ID: 8399562 [TBL] [Abstract][Full Text] [Related]
4. The constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyloxidase type II activity in disorders with variable aldosterone production. Kater CE; Biglieri EG; Rost CR; Schambelan M; Hirai J; Chang BC; Brust N J Clin Endocrinol Metab; 1985 Feb; 60(2):225-8. PubMed ID: 2981240 [TBL] [Abstract][Full Text] [Related]
5. Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism. Witzgall H; Lorenz R; von Werder K; Weber PC Clin Sci (Lond); 1985 Mar; 68(3):291-9. PubMed ID: 3882312 [TBL] [Abstract][Full Text] [Related]
6. Rapid increase of mineralocorticoids after furosemide in low-renin essential hypertension: evidence for 18-hydroxycorticosterone to be a better marker than aldosterone. Witzgall H; Thayil G; Weber PC Klin Wochenschr; 1982 Aug; 60(16):847-52. PubMed ID: 6752560 [TBL] [Abstract][Full Text] [Related]
8. Studies of renin activation and regulation of aldosterone and 18-hydroxycorticosterone biosynthesis in hyporeninemic hypoaldosteronism. Sowers JR; Beck FW; Waters BK; Barrett JD; Welch BG J Clin Endocrinol Metab; 1985 Jul; 61(1):60-7. PubMed ID: 2987296 [TBL] [Abstract][Full Text] [Related]
9. Renin, aldosterone and other mineralocorticoids in hyperkalemic patients with chronic renal failure showing mild azotemia. Saruta T; Nagahama S; Eguchi T; Oka M; Kanbegawa A Nephron; 1981; 29(3-4):128-32. PubMed ID: 7035983 [TBL] [Abstract][Full Text] [Related]
10. The significance of elevated levels of plasma 18-hydroxycorticosterone in patients with primary aldosteronism. Biglieri EG; Schambelan M J Clin Endocrinol Metab; 1979 Jul; 49(1):87-91. PubMed ID: 447820 [TBL] [Abstract][Full Text] [Related]
11. Effect of domperidone, an extracerebral inhibitor of dopamine receptors, on thyrotropin, prolactin, renin, aldosterone, and 18-hydroxycorticosterone secretion in man. Sowers JR; Sharp B; McCallum RW J Clin Endocrinol Metab; 1982 Apr; 54(4):869-71. PubMed ID: 7037817 [TBL] [Abstract][Full Text] [Related]
12. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis. Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992 [TBL] [Abstract][Full Text] [Related]
13. Chronic renal replacement therapy in children: which index is best for adequacy? Verrina E; Brendolan A; Gusmano R; Ronco C Kidney Int; 1998 Nov; 54(5):1690-6. PubMed ID: 9844146 [TBL] [Abstract][Full Text] [Related]
14. Trace elements in hemodialysis and continuous ambulatory peritoneal dialysis patients. Zima T; Mestek O; Nĕmecek K; Bártová V; Fialová J; Tesar V; Suchánek M Blood Purif; 1998; 16(5):253-60. PubMed ID: 9917533 [TBL] [Abstract][Full Text] [Related]
15. Corticosterone methyloxidase II activity during hemodialysis. Zager PG; Spalding CT; Frey HJ; Brittenham MC J Lab Clin Med; 1987 Feb; 109(2):178-83. PubMed ID: 3543178 [TBL] [Abstract][Full Text] [Related]
16. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis. Mottet JJ; Horber FF; Casez JP; Descoeudres C; Jaeger P J Bone Miner Res; 1996 Jan; 11(1):96-104. PubMed ID: 8770702 [TBL] [Abstract][Full Text] [Related]
17. Plasma levels of human atrial natriuretic factor in patients treated by hemodialysis and continuous ambulatory peritoneal dialysis. Ando R; Matsuda O; Miyake S; Yoshiyama N Nephron; 1988; 50(3):225-8. PubMed ID: 2976122 [TBL] [Abstract][Full Text] [Related]
18. Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis. Chuang CK; Lin SP; Chen HH; Chen YC; Wang TJ; Shieh WH; Wu CJ Clin Chim Acta; 2006 Feb; 364(1-2):209-16. PubMed ID: 16087168 [TBL] [Abstract][Full Text] [Related]
19. Significance of brain natriuretic peptides in patients on continuous ambulatory peritoneal dialysis. Nakatani T; Naganuma T; Masuda C; Uchida J; Sugimura T; Sugimura K Int J Mol Med; 2002 Oct; 10(4):457-61. PubMed ID: 12239593 [TBL] [Abstract][Full Text] [Related]
20. Comparison of plasma amino acid concentrations in end-stage renal disease patients on hemodialysis and peritoneal dialysis. Kim DH; Yang DH; Hong SY Korean J Intern Med; 1998 Feb; 13(1):33-40. PubMed ID: 9538629 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]